Approaches towards rational antiviral chemotherapy

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• Epidemic influenza remains difficult to control with existing immune (prophylaxis) or drug (chemoprophylaxis) strategies.
• Influenza virus frequently mutates, leading to new strains that evade herd immunity and drug resistance through gene reassortment.

Purpose of the Study:

• To explore combined immuno- and chemoprophylaxis for more effective influenza control.
• To investigate semi-rational chemotherapy using specific enzyme assays for novel antiviral compound development.
• To identify potential targets for a new generation of antiviral compounds through molecular studies.

Main Methods:

• Review of current limitations in influenza prophylaxis.
• Discussion of in vitro selection of drug-resistant viruses and gene reassortment.
• Exploration of virion-associated RNA transcriptase assays for semi-rational drug discovery.
• Mention of ongoing RNA and polypeptide sequence studies for identifying viral targets.
• Consideration of liposomes for targeted delivery of antiviral agents.

Main Results:

• Current immuno- and chemoprophylaxis are insufficient against epidemic influenza.
• Influenza virus readily develops drug resistance and antigenic variants.
• Semi-rational chemotherapy and molecular studies show promise for new antiviral development.
• Liposomes are a potential delivery system for antiviral compounds.

Conclusions:

• Combined immuno- and chemoprophylaxis may offer a superior approach to influenza control.
• Developing novel antiviral compounds through targeted assays and molecular insights is crucial.
• Advanced drug delivery systems like liposomes warrant further investigation for enhanced efficacy.